← Back to Search

Mobile Health Tool for Concussions

N/A
Recruiting
Led By Daniel J Corwin, MD, MSCE
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 1 year of completing study procedures
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test if a mobile health tool can help teenagers with concussions get better care. Patients will use an app to report their symptoms and activity daily, and the app will connect them to

Who is the study for?
This trial is for 13-18 year olds who've had a concussion and are at moderate-to-high risk of long-term symptoms. They must have been to the Children's Hospital of Philadelphia within 72 hours of injury, own a smartphone, and meet specific medical criteria for concussion severity.
What is being tested?
The study tests an mHealth tool that tracks patient symptoms daily via chat technology linked to their health records. It aims to improve specialist access and care coordination for young patients with traumatic brain injuries.
What are the potential side effects?
Since this trial involves using a mobile health tool rather than medication, traditional side effects aren't expected. However, there may be privacy concerns or stress related to daily symptom reporting.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 1 year of completing study procedures
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 1 year of completing study procedures for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Incidence of Persisting Post-Concussion Symptoms (PPCS, Primary Effectiveness)
Percent of participants meeting referral criteria who interact with a specialty care provider (Fidelity, Primary Implementation)
Secondary study objectives
Days until clearance (Secondary Effectiveness)
Days until return to school (Secondary Effectiveness)
Days until return to symptoms baseline (Secondary Effectiveness)
+5 more
Other study objectives
Incidence of Persistent Post-Concussion Symptoms (PPCS)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Concussed youth at risk for prolonged symptomsExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
731 Previous Clinical Trials
8,472,602 Total Patients Enrolled
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,378 Previous Clinical Trials
651,982 Total Patients Enrolled
Daniel J Corwin, MD, MSCEPrincipal InvestigatorChildren's Hospital of Philadelphia
~140 spots leftby Sep 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top